These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8780301)

  • 41. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Goforth HW; Carroll BT
    J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
    [No Abstract]   [Full Text] [Related]  

  • 42. Tranylcypromine: new perspectives on an "old" drug.
    Frieling H; Bleich S
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):268-73. PubMed ID: 16927039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES].
    GRATTAROLA FR; ROSSO G; ROVERA GG
    Clin Ter; 1963 Sep; 26():406-30. PubMed ID: 14091908
    [No Abstract]   [Full Text] [Related]  

  • 44. Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome.
    Miller F; Friedman R; Tanenbaum J; Griffin A
    J Clin Psychopharmacol; 1991 Aug; 11(4):277-9. PubMed ID: 1918432
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of melancholia with tranylcypromine.
    McGrath PJ; Quitkin FM; Harrison W; Stewart JW
    Am J Psychiatry; 1984 Feb; 141(2):288-9. PubMed ID: 6691499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy.
    Liu LX; Rustgi AK
    Am J Med; 1987 May; 82(5):1060-4. PubMed ID: 3578343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 49. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoamine oxidase inhibitors in depression.
    Brandon S
    Br Med J (Clin Res Ed); 1982 Dec; 285(6355):1594-5. PubMed ID: 6814664
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoamine oxidase inhibitors in depression.
    Rowan P
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):225-6. PubMed ID: 6401540
    [No Abstract]   [Full Text] [Related]  

  • 55. CLINICAL TRIAL WITH THE MONOAMINO OXIDASE INHIBITOR TRANYLCYPROMINE ON A PSYCHIATRIC CLIENTELE.
    Gottfries CG
    Acta Psychiatr Scand; 1963; 39(3):463-72. PubMed ID: 14130294
    [No Abstract]   [Full Text] [Related]  

  • 56. Platelet serotonin response to treatment in geriatric depression.
    McIntyre IM; Norman TR
    Biol Psychiatry; 1989 Aug; 26(4):434-6. PubMed ID: 2765604
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
    Schiwy W; Heath WR; Delini-Stula A
    J Neural Transm Suppl; 1989; 28():33-44. PubMed ID: 2677240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depression and reversible monoamine oxidase inhibitors--new perspectives.
    Br J Psychiatry Suppl; 1989 Oct; (6):1-88. PubMed ID: 2619972
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of tranylcypromine stereoisomers on depressive syndromes.
    Rüther E; Jungkunz G; Greil W; Zimmer R
    Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
    [No Abstract]   [Full Text] [Related]  

  • 60. Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study.
    White K; Pistole T; Boyd JL
    Am J Psychiatry; 1980 Nov; 137(11):1422-5. PubMed ID: 7435677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.